Form 4: Doximity Director Granted 3,221 Restricted Stock Units

Doximity Director Kira Scherer Wampler received a grant of 3,221 restricted stock units as part of her compensation.

Summary

• Kira Scherer Wampler, a Director at Doximity, Inc. (DOCS), was granted 3,221 shares of Class A Common Stock in the form of Restricted Stock Units (RSUs).
• The transaction date for this grant was August 28, 2025.
• The RSUs were granted at a price of $0, indicating they are part of a compensation package rather than a purchase.
• Following this transaction, Ms. Wampler beneficially owns 19,839 shares of Class A Common Stock.
• These RSUs will vest in full on the earlier of (i) the first anniversary of the grant date (August 28, 2026) or (ii) Doximity's next annual meeting of stockholders, contingent on her continued service as a director.

Sentiment

Score: 6

Explanation: The filing reflects a routine, positive event of director compensation, aligning interests without indicating any material operational or financial changes. It's a standard governance practice.

Positives

• The grant of Restricted Stock Units aligns the director's interests with those of the shareholders, as the value of her compensation is tied to the company's stock performance.
• This is a standard practice for compensating non-employee directors, reflecting a structured approach to corporate governance and talent retention.

Future Outlook

The granted Restricted Stock Units are subject to future vesting, contingent upon the director's continued service. Vesting will occur on the earlier of the first anniversary of the grant date or the company's next annual meeting of stockholders.

Industry Context

The grant of Restricted Stock Units to a non-employee director is a common practice across publicly traded companies, particularly in the technology and healthcare sectors. This method of compensation is widely used to attract and retain qualified board members while aligning their financial interests with long-term shareholder value.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) for non-employee director compensation is a standard practice, comparable to policies at companies like Teladoc Health (TDOC) or Veeva Systems (VEEV) in the healthcare technology space, which often utilize equity grants to incentivize long-term commitment and performance.
• The vesting schedule, tied to either an anniversary date or the next annual meeting, is also typical for director equity awards, ensuring continued engagement through the board's operational cycle.

Corporate Governance

Related Party Transactions

• The grant of Restricted Stock Units to Director Kira Scherer Wampler constitutes a related party transaction, as it is compensation provided to a member of the company's board of directors.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's financial incentives with long-term shareholder value, potentially leading to more shareholder-friendly decision-making.
• Employees: No direct impact on general employees is indicated by this filing.
• Directors: Provides compensation and incentivizes continued service and commitment from the board member.

Next Steps

• The Restricted Stock Units will vest on the earlier of August 28, 2026, or Doximity's next annual meeting of stockholders, subject to the director's continued service.

Key Dates

Recommendation

This Form 4 filing details a routine equity grant to a director as part of their compensation. It does not contain any information that would materially alter the fundamental outlook or valuation of Doximity, Inc. Therefore, it does not warrant a change in investment recommendation based solely on this disclosure.

Keywords

Doximity, DOCS, Kira Scherer Wampler, Restricted Stock Units, RSU, Director Compensation, Insider Transaction, Equity Grant, Form 4